All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway

Ho Young Lee, David F. Dohi, Yeul Hong Kim, Garrett L. Walsh, Ugo Consoli, Michael Andreeff, Marcia I. Dawson, Waun Ki Hong, Jonathan M. Kurie

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Retinoids, including retinol and retinoic acid derivatives, maintain the normal growth and differentiation of human bronchial epithelial (HBE) cells and are under investigation as agents for lung cancer prevention. In this study, we examined the biologic effect of retinoids on normal HBE cells and the molecular mechanisms of retinoid actions. At a dose of 10-6 M, all- trans retinoic acid (t-RA) suppressed the proliferation of normal HBE cells, which accumulated in the G0 phase. No evidence of programmed cell death was observed. The class of retinoid nuclear receptor that mediated the growth arrest was explored. Normal HBE cell growth was suppressed by a retinoid that selectively activates retinoic acid receptors but not by one that activates retinoid X receptors. The E2F transcription factor has demonstrated a role in G0 entry through transcriptional suppression of genes that induce cell cycle progression. To investigate the role of E2F in retinoid signaling, transient transfection assays were performed using reporter plasmids containing E2F- binding sites. Findings from these experiments suggested that t-RA treatment converted E2F into a transcriptional suppressor. Supporting this possibility, t-RA inhibited the expression of the E2F target genes B-myb, cyclin A, and cyclin E. Further, t-RA increased the levels of nuclear E2F-4, p107, and p130 and enhanced the binding of E2F-4 to p107, which have been associated with the conversion of E2F into a transcriptional suppressor in other cells. These findings point to retinoic acid receptor- and E2F-dependent pathways as potential mediators of retinoid-induced growth arrest in normal HBE cells and have implications for the use of retinoids in clinical trials on the prevention of lung cancer.

Original languageEnglish
Pages (from-to)1012-1019
Number of pages8
JournalJournal of Clinical Investigation
Volume101
Issue number5
Publication statusPublished - 1998 Mar 1
Externally publishedYes

Fingerprint

Retinoic Acid Receptors
Retinoids
Tretinoin
Epithelial Cells
Growth
Lung Neoplasms
myb Genes
E2F Transcription Factors
Retinoid X Receptors
Cyclin A
cdc Genes
Cyclin E
Cell Cycle Resting Phase
Cytoplasmic and Nuclear Receptors
Vitamin A
Transfection
Plasmids
Cell Death
Binding Sites
Clinical Trials

Keywords

  • p107
  • p130
  • Retinoid nuclear receptor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway. / Lee, Ho Young; Dohi, David F.; Kim, Yeul Hong; Walsh, Garrett L.; Consoli, Ugo; Andreeff, Michael; Dawson, Marcia I.; Hong, Waun Ki; Kurie, Jonathan M.

In: Journal of Clinical Investigation, Vol. 101, No. 5, 01.03.1998, p. 1012-1019.

Research output: Contribution to journalArticle

Lee, Ho Young ; Dohi, David F. ; Kim, Yeul Hong ; Walsh, Garrett L. ; Consoli, Ugo ; Andreeff, Michael ; Dawson, Marcia I. ; Hong, Waun Ki ; Kurie, Jonathan M. / All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway. In: Journal of Clinical Investigation. 1998 ; Vol. 101, No. 5. pp. 1012-1019.
@article{e9ed6ddf842b429ea852bd091616bd95,
title = "All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway",
abstract = "Retinoids, including retinol and retinoic acid derivatives, maintain the normal growth and differentiation of human bronchial epithelial (HBE) cells and are under investigation as agents for lung cancer prevention. In this study, we examined the biologic effect of retinoids on normal HBE cells and the molecular mechanisms of retinoid actions. At a dose of 10-6 M, all- trans retinoic acid (t-RA) suppressed the proliferation of normal HBE cells, which accumulated in the G0 phase. No evidence of programmed cell death was observed. The class of retinoid nuclear receptor that mediated the growth arrest was explored. Normal HBE cell growth was suppressed by a retinoid that selectively activates retinoic acid receptors but not by one that activates retinoid X receptors. The E2F transcription factor has demonstrated a role in G0 entry through transcriptional suppression of genes that induce cell cycle progression. To investigate the role of E2F in retinoid signaling, transient transfection assays were performed using reporter plasmids containing E2F- binding sites. Findings from these experiments suggested that t-RA treatment converted E2F into a transcriptional suppressor. Supporting this possibility, t-RA inhibited the expression of the E2F target genes B-myb, cyclin A, and cyclin E. Further, t-RA increased the levels of nuclear E2F-4, p107, and p130 and enhanced the binding of E2F-4 to p107, which have been associated with the conversion of E2F into a transcriptional suppressor in other cells. These findings point to retinoic acid receptor- and E2F-dependent pathways as potential mediators of retinoid-induced growth arrest in normal HBE cells and have implications for the use of retinoids in clinical trials on the prevention of lung cancer.",
keywords = "p107, p130, Retinoid nuclear receptor",
author = "Lee, {Ho Young} and Dohi, {David F.} and Kim, {Yeul Hong} and Walsh, {Garrett L.} and Ugo Consoli and Michael Andreeff and Dawson, {Marcia I.} and Hong, {Waun Ki} and Kurie, {Jonathan M.}",
year = "1998",
month = "3",
day = "1",
language = "English",
volume = "101",
pages = "1012--1019",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway

AU - Lee, Ho Young

AU - Dohi, David F.

AU - Kim, Yeul Hong

AU - Walsh, Garrett L.

AU - Consoli, Ugo

AU - Andreeff, Michael

AU - Dawson, Marcia I.

AU - Hong, Waun Ki

AU - Kurie, Jonathan M.

PY - 1998/3/1

Y1 - 1998/3/1

N2 - Retinoids, including retinol and retinoic acid derivatives, maintain the normal growth and differentiation of human bronchial epithelial (HBE) cells and are under investigation as agents for lung cancer prevention. In this study, we examined the biologic effect of retinoids on normal HBE cells and the molecular mechanisms of retinoid actions. At a dose of 10-6 M, all- trans retinoic acid (t-RA) suppressed the proliferation of normal HBE cells, which accumulated in the G0 phase. No evidence of programmed cell death was observed. The class of retinoid nuclear receptor that mediated the growth arrest was explored. Normal HBE cell growth was suppressed by a retinoid that selectively activates retinoic acid receptors but not by one that activates retinoid X receptors. The E2F transcription factor has demonstrated a role in G0 entry through transcriptional suppression of genes that induce cell cycle progression. To investigate the role of E2F in retinoid signaling, transient transfection assays were performed using reporter plasmids containing E2F- binding sites. Findings from these experiments suggested that t-RA treatment converted E2F into a transcriptional suppressor. Supporting this possibility, t-RA inhibited the expression of the E2F target genes B-myb, cyclin A, and cyclin E. Further, t-RA increased the levels of nuclear E2F-4, p107, and p130 and enhanced the binding of E2F-4 to p107, which have been associated with the conversion of E2F into a transcriptional suppressor in other cells. These findings point to retinoic acid receptor- and E2F-dependent pathways as potential mediators of retinoid-induced growth arrest in normal HBE cells and have implications for the use of retinoids in clinical trials on the prevention of lung cancer.

AB - Retinoids, including retinol and retinoic acid derivatives, maintain the normal growth and differentiation of human bronchial epithelial (HBE) cells and are under investigation as agents for lung cancer prevention. In this study, we examined the biologic effect of retinoids on normal HBE cells and the molecular mechanisms of retinoid actions. At a dose of 10-6 M, all- trans retinoic acid (t-RA) suppressed the proliferation of normal HBE cells, which accumulated in the G0 phase. No evidence of programmed cell death was observed. The class of retinoid nuclear receptor that mediated the growth arrest was explored. Normal HBE cell growth was suppressed by a retinoid that selectively activates retinoic acid receptors but not by one that activates retinoid X receptors. The E2F transcription factor has demonstrated a role in G0 entry through transcriptional suppression of genes that induce cell cycle progression. To investigate the role of E2F in retinoid signaling, transient transfection assays were performed using reporter plasmids containing E2F- binding sites. Findings from these experiments suggested that t-RA treatment converted E2F into a transcriptional suppressor. Supporting this possibility, t-RA inhibited the expression of the E2F target genes B-myb, cyclin A, and cyclin E. Further, t-RA increased the levels of nuclear E2F-4, p107, and p130 and enhanced the binding of E2F-4 to p107, which have been associated with the conversion of E2F into a transcriptional suppressor in other cells. These findings point to retinoic acid receptor- and E2F-dependent pathways as potential mediators of retinoid-induced growth arrest in normal HBE cells and have implications for the use of retinoids in clinical trials on the prevention of lung cancer.

KW - p107

KW - p130

KW - Retinoid nuclear receptor

UR - http://www.scopus.com/inward/record.url?scp=0032030991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032030991&partnerID=8YFLogxK

M3 - Article

VL - 101

SP - 1012

EP - 1019

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -